Royalty Pharma Plc Stock Price History

Royalty Pharma Stock Price History Chart

Royalty Pharma August 5, 2025 Stock Price Synopsis

Various analyses of Royalty Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Royalty Stock. It can be used to describe the percentage change in the price of Royalty Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Royalty Stock. When benchmark price declines in a down market, there may be an uptick in Royalty Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Royalty Pharma intraday prices and daily technical indicators to check the level of noise trading in Royalty Stock and then apply it to test your longer-term investment strategies against Royalty.

Royalty Stock Price History Data

The price series of Royalty Pharma for the period between Wed, May 7, 2025 and Tue, Aug 5, 2025 has a statistical range of 5.98 with a coefficient of variation of 4.76. The price distribution for the period has arithmetic mean of 34.62. The median price for the last 90 days is 34.91. The company completed stock split (1:4) on 15th of October 2010. Royalty Pharma Plc had dividends distributed to its stock-holders on 2025-08-15.

Royalty Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Royalty is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Royalty Pharma Plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Royalty Pharma stock prices may prove useful in developing a viable investing in Royalty Pharma

Royalty Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Predictive indicators are helping investors to find signals for Royalty Pharma's price direction in advance. Along with the technical and fundamental analysis of Royalty Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Royalty to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.